Research Focus: Cancer Immunotherapeutics & HSCT

Kiadis Pharma is focused on patient specific cell-based immunotherapy products for the treatment of life threatening diseases. Kiadis is focused on developing new cancer immunotherapeutics as well as novel adjunctive treatments for patients undergoing hematopoietic stem cell transplants.